Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27809111 | 0.83 | HSD17B10 (0.40) | HSD17B10LMNANPC1KDM4EGAA | |
| SCHEMBL3732334 | 0.81 | HSD17B10 (0.39) | HSD17B10LMNANPC1KDM4EGAA | |
| SCHEMBL9446120 | 0.78 | HSD17B10 (0.38) | HSD17B10LMNANPC1KDM4EGAA | |
| Tert-Butanol SCHEMBL8465422 | 0.77 | LMNA (0.43) | HSD17B10LMNANPC1KDM4EGAA | |
| SCHEMBL180902 | 0.76 | — | — | |
| SCHEMBL5804830 | 0.75 | HSD17B10 (0.36) | HSD17B10LMNAMAPT | |
| SCHEMBL20508241 | 0.75 | HSD17B10 (0.41) | HSD17B10LMNANPC1KDM4EGAA | |
| SCHEMBL9446118 | 0.73 | HSD17B10 (0.35) | HSD17B10LMNA | |
| Methoxymethane SCHEMBL108410 | 0.73 | LMNA (0.43) | HSD17B10LMNANPC1KDM4EGAA | |
| SCHEMBL27647833 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10626351-B2 | Treatment compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-04-21 | — | — | US | claimed |
| EP-2756067-B1 | MICROCAPSULE COMPOSITIONS COMPRISING PH TUNEABLE DI-AMIDO GELLANTS | PROCTER & GAMBLE (US) | 2017-06-14 | — | — | EP | claimed |
| EP-2756067-A1 | MICROCAPSULE COMPOSITIONS COMPRISING PH TUNEABLE DI-AMIDO GELLANTS | The Procter & Gamble Company (US) | 2014-07-23 | — | — | EP | claimed |
| US-20130303427-A1 | MICROCAPSULE COMPOSITIONS COMPRISING pH TUNEABLE DI-AMIDO GELLANTS | THE PROCTER & GAMBLE COMPANY | 2013-11-14 | — | — | US | claimed |
| WO-2013039963-A1 | MICROCAPSULE COMPOSITIONS COMPRISING PH TUNEABLE DI-AMIDO GELLANTS | THE PROCTER & GAMBLE COMPANY (US) | 2013-03-21 | — | — | WO | claimed |
| US-11999843-B2 | Polyvinyl alcohol compositions with eutectic solvents, articles thereof, and methods of making same | THE PROCTER & GAMBLE COMPANY (US) | 2024-06-04 | — | — | US | disclosed |
| EP-3575339-B1 | DRYER SHEETS COMPRISING BRANCHED POLYESTER POLYMERS | PROCTER & GAMBLE (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-4362705-A1 | SPRAY NOZZLE FOR DISPENSING A STRUCTURED COMPOSITION AND A SPRAY PRODUCT COMPRISING THE SAME | The Procter & Gamble Company (US) | 2024-05-08 | — | — | EP | disclosed |
| US-11925733-B2 | Malodor counteractant composition and methods | BELL FLAVORS & FRAGRANCES, INC. (US) | 2024-03-12 | — | — | US | disclosed |
| US-20240060016-A1 | Low-Water Compositions | THE PROCTER & GAMBLE COMPANY | 2024-02-22 | — | — | US | disclosed |
| US-20240060015-A1 | SOLID DISSOLVABLE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2024-02-22 | — | — | US | disclosed |
| US-20240060014-A1 | LOW-WATER COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2024-02-22 | — | — | US | disclosed |
| EP-2756067-A1 | MICROCAPSULE COMPOSITIONS COMPRISING PH TUNEABLE DI-AMIDO GELLANTS | The Procter & Gamble Company (US) | 2014-07-23 | — | — | EP | disclosed |
| US-20130303427-A1 | MICROCAPSULE COMPOSITIONS COMPRISING pH TUNEABLE DI-AMIDO GELLANTS | THE PROCTER & GAMBLE COMPANY | 2013-11-14 | — | — | US | disclosed |
| WO-2013039963-A1 | MICROCAPSULE COMPOSITIONS COMPRISING PH TUNEABLE DI-AMIDO GELLANTS | THE PROCTER & GAMBLE COMPANY (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013039964-A1 | STABLE WATER-SOLUBLE UNIT DOSE ARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040115-A1 | FLUID FABRIC ENHANCER COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2013-03-21 | — | — | WO | disclosed |
| EP-2570474-A1 | Stable water-soluble unit dose articles | The Procter and Gamble Company (US) | 2013-03-20 | — | — | EP | disclosed |
| US-20130065813-A1 | FLUID FABRIC ENHANCER COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2013-03-14 | — | — | US | disclosed |
| US-20130065811-A1 | STABLE WATER-SOLUBLE UNIT DOSE ARTICLE | THE PROCTER & GAMBLE COMPANY | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065811-A1 | STABLE WATER-SOLUBLE UNIT DOSE ARTICLE | IDUA, AQP1, DLST | HSD17B10 4431/4885LMNA 2053/4885NPC1 1968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.